WO2012007623A3 - Oligonucleotide-activated controlled-release system - Google Patents

Oligonucleotide-activated controlled-release system Download PDF

Info

Publication number
WO2012007623A3
WO2012007623A3 PCT/ES2011/070507 ES2011070507W WO2012007623A3 WO 2012007623 A3 WO2012007623 A3 WO 2012007623A3 ES 2011070507 W ES2011070507 W ES 2011070507W WO 2012007623 A3 WO2012007623 A3 WO 2012007623A3
Authority
WO
WIPO (PCT)
Prior art keywords
release system
oligonucleotide
controlled
activated controlled
activated
Prior art date
Application number
PCT/ES2011/070507
Other languages
Spanish (es)
French (fr)
Other versions
WO2012007623A2 (en
Inventor
Estela Climent Terol
María Dolores MARCOS MARTÍNEZ
Ramón MARTÍNEZ MAÑEZ
Félix SANCENON GALARZA
Juan Soto Camino
Original Assignee
Universidad Politécnica De Valencia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Politécnica De Valencia filed Critical Universidad Politécnica De Valencia
Publication of WO2012007623A2 publication Critical patent/WO2012007623A2/en
Publication of WO2012007623A3 publication Critical patent/WO2012007623A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

The invention describes a novel system for the controlled release preferably of active substances or detection substances in response to the presence of oligonucleotides as specific stimulus. Furthermore, a preparation method for systems containing the above-mentioned controlled-release system has been developed, together with a method for the determination of specific nucleic acid sequences in aqueous solutions.
PCT/ES2011/070507 2010-07-12 2011-07-08 Oligonucleotide-activated controlled-release system WO2012007623A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP201000900 2010-07-12
ES201000900A ES2377298B1 (en) 2010-07-12 2010-07-12 CONTROLLED RELEASE SYSTEM ACTIVATED BY OLIGONUCLEOTIDES.

Publications (2)

Publication Number Publication Date
WO2012007623A2 WO2012007623A2 (en) 2012-01-19
WO2012007623A3 true WO2012007623A3 (en) 2012-03-08

Family

ID=45469850

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2011/070507 WO2012007623A2 (en) 2010-07-12 2011-07-08 Oligonucleotide-activated controlled-release system

Country Status (2)

Country Link
ES (1) ES2377298B1 (en)
WO (1) WO2012007623A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2692165B2 (en) * 2018-05-29 2019-04-08 Univ Valencia Politecnica CONTROLLED RELEASE SYSTEM AND METHOD OF PREPARATION OF THE SAME

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009602A2 (en) * 2003-07-22 2005-02-03 Iowa State University Research Foundation, Inc. Capped mesoporous silicates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009602A2 (en) * 2003-07-22 2005-02-03 Iowa State University Research Foundation, Inc. Capped mesoporous silicates

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CLIMENT, E. ET AL.: "Controlled Delivery Systems Using Antibody-Capped Mesoporous Nanocontainers.", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 131, no. 39, 9 September 2009 (2009-09-09), pages 14075 - 14080 *
CLIMENT, E. ET AL.: "Controlled Delivery Using Oligonucleotide-Capped Mesoporous Silica Nanoparticles.", ANGEWANDTE CHEMIE, vol. 49, no. 40, 24 August 2010 (2010-08-24), pages 7281 - 7283 *
SADASIVAN, S. ET AL.: "DNA-Driven Assembly of Mesoporous Silica/Gold Satellite Nanostructures.", SMALL., vol. 1, no. 1., January 2005 (2005-01-01), pages 103 - 106 *
SOLBERG, S.M. ET AL.: "Adsorption of DNA into Mesoporous Silica.", JOURNAL OF PHYSICAL CHEMISTRY B., vol. 110, no. 31, 10 August 2006 (2006-08-10), pages 15261 - 15268 *

Also Published As

Publication number Publication date
ES2377298B1 (en) 2013-08-13
WO2012007623A2 (en) 2012-01-19
ES2377298A1 (en) 2012-03-26

Similar Documents

Publication Publication Date Title
WO2013154999A3 (en) Method of preparation of nanopore and uses thereof
HK1257301A1 (en) Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
GB2517875A (en) Modified base detection with nanopore sequencing
WO2013096838A3 (en) Systems and methods for isolating nucleic acids
WO2012125987A3 (en) Delivery system
WO2013150082A8 (en) Hybridization-based replication of nucleic acid molecules
WO2013159108A3 (en) Oligomeric compounds comprising bicyclic nucleotides and uses thereof
WO2010088517A8 (en) Methods and systems for purifying transferring and/or manipulating nucleic acids
WO2012092515A9 (en) Methods, systems, and computer readable media for nucleic acid sequencing
BRPI1011227A2 (en) microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid.
EP2524056A4 (en) Multiplex amplification for the detection of nucleic acid variations
ZA201405463B (en) Detection of target nucleic acid sequence by pto cleavage and extension-dependent signaling oligonucleotide hybridization assay
WO2008073959A3 (en) Synthetic agonists of tlr9
WO2012088348A3 (en) Fetal genetic variation detection
WO2012095639A3 (en) Methods, compositions, and kits for determing the presence/absence of a varian nucleic acid sequence
WO2012135053A3 (en) Rnase h-based assays utilizing modified rna monomers
WO2013050881A3 (en) Direct nucleic acid analysis
WO2009089076A3 (en) Processes for the preparation and purification of paliperidone palmitate
WO2012135658A3 (en) Sequence preserved dna conversion for optical nanopore sequencing
WO2011116256A3 (en) Multiphase microarrays and uses thereof
WO2013068850A3 (en) PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES
WO2014005125A3 (en) Fluorescent compounds and uses thereof
EP2455487A4 (en) Chromatographic system for nucleic acid detection
WO2009117498A3 (en) Methods of making cyclododecatriene and methods of making laurolactone
FR2964331B1 (en) CHEMICALLY STABILIZED MEMBRANE, PROCESS FOR PREPARING THE SAME AND USES THEREOF

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11806342

Country of ref document: EP

Kind code of ref document: A2